Most cited papers from Cancéropôle Est

Cancéropôle Est

What are the most cited papers from Cancéropôle Est?

The most cited paper from Cancéropôle Est is "The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression" (Federica Babbio, Christian Pistore, Laura Curti et al., 2012), with 137 citations. Next come "The PHD Domain of Np95 (mUHRF1) Is Involved in Large-Scale Reorganization of Pericentromeric Heterochromatin" (69) and "Development and validation of the FRAGIRE tool for assessment an older person’s risk for frailty" (43).

Published FieldAccess

Showing 17 of 17 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression Federica Babbio, Christian Pistore, Laura Curti et al. · Oncogene	13 Feb 2012	137
2	The PHD Domain of Np95 (mUHRF1) Is Involved in Large-Scale Reorganization of Pericentromeric Heterochromatin Roberto Papait, Christian Pistore, Ursula Grazini et al. · Molecular Biology of the Cell Open access	28 May 2008	69
3	Development and validation of the FRAGIRE tool for assessment an older person’s risk for frailty Déwi Vernerey, Amélie Anota, Pierre Vandel et al. · BMC Geriatrics Open access	17 Nov 2016	43
4	Pooled analysis of 115 patients from updated data of Epitopes-HPV01 and Epitopes-HPV02 studies in first-line advanced anal squamous cell carcinoma Stefano Chong Hun Kim et al. · Therapeutic Advances in Medical Oncology Open access	2020	34
5	A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study Magali Rebucci-Peixoto, Angélique Vienot, Olivier Adotévi et al. · Frontiers in Oncology Open access	19 Jul 2022	28
6	Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial Stefano Chong Hun Kim et al. · BMC Cancer Open access	25 Apr 2020	27
7	Docetaxel, Cisplatin, and 5-fluorouracil (DCF) chemotherapy in the treatment of metastatic or unresectable locally recurrent anal squamous cell carcinoma: a phase II study of French interdisciplinary GERCOR and FFCD groups (Epitopes-HPV02 study) Stefano Chong Hun Kim et al. · BMC Cancer Open access	25 Aug 2017	23
8	Fatty acid composition of the erythrocyte membrane and risk of hepatocellular carcinoma in cirrhotic patients Thomas Mouillot et al. · Alimentary Pharmacology & Therapeutics	11 Aug 2020	17
9	Evaluation of efficacy and efficiency of a pragmatic intervention by a social worker to support informal caregivers of elderly patients (The ICE Study): study protocol for a randomized controlled trial Astrid Pozet, Catherine Lejeune, Magalie Bonnet et al. · Trials Open access	3 Nov 2016	16
10	DCF versus doublet chemotherapy as first-line treatment of advanced squamous anal cell carcinoma: a multicenter propensity score-matching study Stefano Chong Hun Kim et al. · Experimental Hematology and Oncology Open access	21 Jul 2023	10
11	Second-line treatment after docetaxel, cisplatin and 5-fluorouracil in metastatic squamous cell carcinomas of the anus. Pooled analysis of prospective Epitopes-HPV01 and Epitopes-HPV02 studies Morgane Stouvenot et al. · European Journal of Cancer Open access	4 Jan 2022	10
12	Exposure‐response analysis of Raltitrexed assessing liver toxicity Bernard Royer, Antonin Schmitt, Thierry Nguyen et al. · British Journal of Clinical Pharmacology Open access	13 Aug 2020	10
13	24th Annual Conference of the International Society for Quality of Life Research Fabio Efficace et al. · Quality of Life Research	12 Sep 2017	4
14	Tandem versus single haematopoietic stem cell transplant and BV maintenance in relapsed/refractory Hodgkin lymphoma: A matched cohort analysis from the LYSA Amira Marouf, Nicolas Molinari, David Sibon et al. · British Journal of Haematology Open access	16 May 2023	3
15	A simple and fast LC–MS/MS method with a very high sensitivity for the measurement of raltitrexed in human plasma Stefano Chong Hun Kim, Amaëlle Bisch, Damien Montange et al. · Journal of Chromatography B	14 Jun 2017	3
16	Humoral immune depression following autologous stem cell transplantation is a marker of prolonged response duration in patients with mantle cell lymphoma Louise Bouard, Benoît Tessoulin, Catherine Thiéblemont et al. · Haematologica Open access	17 Feb 2022	2
17	Contribution des responsables des Cancéropôles au Forum/Débat sur le bilan des actions des Cancéropôles Christian Chabannon, Philippe Bougnoux, Gilles Favre et al. · médecine/sciences Open access	Oct 2014	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.